LGVN Gunggung Aset Perusahaan Longeveron Corporation

LGVN (Longeveron Inc) - tandha merek perusahaan

Longeveron Inc. (LGVN) specializes in the development of Lomecel-B, leveraging test results for heart hypoplasia and Alzheimer's disease. Its operations are protected by US laws, which eliminates geopolitical risks. The historical price action of total assets, reaching 16.12, is illustrated below. The team consists of elite biologists retained through generous stock options and grants to combat age-related pathologies.

Longeveron Corp (LGVN) - Total Aset Perusahaan saka 04.07.2022 nganti 30.10.2026

Rincian metrik keuangan lan pasar Longeveron Corp (LGVN)

- kuotasi lan prakiraan analis:
Kurs saham longeveron.com|LGVN - Bagan rega target
- data kapitalisasi pasar:
Kapitalisasi pasar Longeveron Corporation|LGVN - Rega Nyata Tumbas Perusahaan Kanthi Wutuh
- data nilai buku modal saham:
Rega Buku Saham Longeveron|LGVN - Kapitalisasi Buku|Koefisien Nilai Pasar marang Nilai Buku longeveron.com|LGVN - Aset Agregat Perusahaan
- informasi babagan utang lan solvabilitas:
Rasio Total Utang marang Ekuitas Longeveron Inc.|LGVN - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Longeveron Corporation|LGVN - Gunggung utang perusahaan|Utang-utang marang nilai buku Longeveron Corporation|LGVN - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Longeveron|Likuiditas cepet longeveron.com
- indikator bathi lan kelipatan valuasi:
LGVN - Bathi resik perusahaan
Pambiji fundamental:LGVN longeveron.com
Barang utama Longeveron Inc.

Institutional capital assesses the attractiveness of Longeveron Inc. (LGVN) based on the volume of resources required to complete clinical trials, as the success of cell therapy depends on treatment efficacy rather than market cycles. The dynamics of the company's total resources, calculated inversely via ROA, allow for the identification of accounting anomalies and an assessment of the asset's real material base to mitigate delisting risks.

Pesaing utama

Total Aset Bisnis MESO|Aset Agregat Perusahaan Lineage Cell Therapeutics, Inc.|Surrozen Inc (SRZN) - Gunggung Aset Perusahaan|Gunggung Aset Perusahaan CCEL (Cryo-Cell International)|Aset Agregat Bisnis FBLG|Total Aset Perusahaan BRTX (BioRestorative Therapies, Inc.)|Creative Medical Technology Holdings, Inc. (CELZ) - Aset Perusahaan